#1TRUFLOWER CENTRATES FSOTIONS Truliev R Investor Presentation / May 2023 CSE: TRUL OTCQX: TCNNF#2www.trulieve.com Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms "Trulieve," "we," "us" and "our" in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian securities legislation (collectively herein referred to as "forward-looking statements"), which can often be identified by words such as "will", "may", "estimate", "expect", "plan", "project", "intend", "anticipate" and other words indicating that the statements are forward-looking. These forward-looking statements relate to Trulieve's expectations or forecasts of business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs and include statements regarding Trulieve's 2023 objectives for cash generation and preservation and investment, Trulieve's financial targets, and its plans for potential acquisitions and expansion of the Company's operations. Such forward-looking statements are expectations only and are subject to known and unknown risks, uncertainties and other important factors, including, but not limited to, risk factors included in this presentation, that could cause the Company's actual results, performance or achievements or industry results to differ materially from any future results, performance or achievements implied by such forward-looking statements. Such risks and uncertainties include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses; engaging in activities which currently are illegal under United States federal law and the uncertainty of existing protection from United States federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including United States state-law legalization, particularly in Florida, due to inconsistent public opinion, perception of the medical-use and adult-use cannabis industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; reliance on management; and the effect of capital market conditions and other factors on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Although it may voluntarily do so from time to time, the Company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Unless otherwise noted, the forecasted industry and market data contained herein are based upon management estimates and industry and market publications and surveys. The information from industry and market publications has been obtained from sources believed to be reliable, but there can be no assurance as to the accuracy or completeness of the included information. The Company has not independently verified any of the data from third-party sources, nor has the Company ascertained the underlying economic assumptions relied upon therein. While such information is believed to be reliable for the purposes used herein, the Company makes no representation or warranty with respect to the accuracy of such information. PLEASE NOTE: MARIJUANA IS ILLEGAL UNDER U.S. FEDERAL LAW, INCLUDING ITS CONSUMPTION, POSSESSION, CULTIVATION, DISTRIBUTION, MANUFACTURING, DISPENSING, AND POSSESSION WITH INTENT TO DISTRIBUTE. Forward-looking statements made in this document are made only as of the date of their initial publication, and the Company undertakes no obligation to publicly update any of these forward-looking statements as actual events unfold. 2#3www.trulieve.com Management's Use of Non-GAAP Financial Measures In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP financial measures, including adjusted gross profit, adjusted net income, adjusted earnings per share, and adjusted EBITDA. Our management uses these non-GAAP financial measures in conjunction with GAAP financial measures to evaluate our operating results and financial performance. We believe these measures are useful to investors as they are widely used measures of performance and can facilitate comparison to other companies. These non-GAAP financial measures are not, and should not be considered as measures of liquidity. These non-GAAP financial measures have limitations as analytical tools in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Because of these limitations, these non- GAAP financial measures should be considered along with GAAP financial performance measures. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with GAAP. Investors are encouraged to review the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures. A reconciliation of the non-GAAP financial measures to such GAAP measures can be found below. These non-GAAP financial measures should be considered supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. 3#4Vision, Mission, and Purpose. Thieve HYBRID www.trulieve.com INDICA TruFlower WHOL Trulieve 35g 125 Tru HYBRID how Trulieve Trulieve TruClear Synge HYBRIE TruFlower minis Trulieve 351 1254 C Trulieve NYARIS Truiene SATIYA Trulieve SATIVA Traieve INDICA Tuo Trulieve TraPOD INDICA Vision We aspire to be the leading customer-focused cannabis brand in the United States, with depth in the markets we choose to operate in. Mission We aim to provide the highest level of cannabis products and customer experience through authentic and reciprocal relationships. Purpose We exist to cultivate human potential. 4#5186 Dispensaries (as of April 30, 2023) Hoon PS 3 U.S. Hubs (leading retail presence in Arizona, Florida, Pennsylvania, and West Virginia) >4.0M ft² Cultivation and Processing, (as of December 31, 2022) 20 Consecutive quarters profitability (December 31, 2022)#6www.trulieve.com Trulieve At A Glance Trulieve is a leading vertically integrated U.S. multi-state cannabis operator • First Florida licensed operator with initial sales in 2016 • Completed RTO on CSE in September 2018 Established operations across three regional hubs: Southeast, Northeast, and Southwest >4 million square feet of cultivation and processing capacity as of December 31, 2022 186 retail dispensaries as of April 30, 2023 Leading retail presence in Arizona, Florida, Pennsylvania, and West Virginia Excellent track record of profitable growth and prudent capital allocation • 20 consecutive profitable quarters through December 2022 Targeted approach with balance between organic growth and M&A Disciplined capital allocation with adherence to strategy and criteria 6#7Indica onl nl nl Vapes Canal (CBD) Welcome Growth Initiatives#8www.trulieve.com Strategic Priorities Deliver Exceptional Customer Experiences and Build Brand Loyalty • Provide superb service, expedient transactions, and frictionless returns . Innovate across product and consumer categories Expand Distribution of Branded Products Through Branded Retail Locations Invest in cornerstone markets: Florida, Pennsylvania, and Arizona • Expand in new and existing markets Focus on Cash Generation and Preservation . Optimize operations, gain efficiencies, and reduce costs • Reduce inventory Invest in infrastructure and technology platforms to support future growth 8#9www.trulieve.com Cannabis 2.0 is the Future Triggered by Regulatory Reform . Precise timing and outcome are unknown . ● May include interstate commerce and/or age-restricted access models Open and diverse competitive landscape with robust industry ecosystem Drivers of Success within Integrated Digital Commerce . . . . Meaningful customer relationships Scale and depth to meet high volume demand Distribution network across multiple channels Technology platforms and scaled solutions Trulieve is well positioned and will continue to invest . . • . . Customer journey enhanced by convenience and personalized marketing Regional hub strategy: teams and operations to serve geographic areas Scale and depth in core markets with >4 million square feet capacity Distribution network with 186 retail locations and wholesale channels Technology platforms and scaled solutions: SAP, Customer Data Platform 9#10www.trulieve.com Customer Experience Introducing Trulieve TruTank mos are here anywhere weh 10 SMG TruTonic $25 el Make your owe but by som 40 pochets inapeuter fast acting relief with long lasting effects. All you need to d add water or any other liquid and you free and low calore padots are Black Cherry and Florida Orange The pede lance of tr for an awesome pick me your day eve labe Black Cherry Florida Orange Thank You! RATION Customer Experience • Service Journey Frictionless Returns • Loyalty program New and Innovative Products • • Live Budder, Live Diamonds, Live Meringue, Live Resin, Live Sauz carts, Live Suga Ratio products, including CBG and CBN RSO tinctures Focus on Customer Retention 66% companywide in q4:22 76% medical only in q4:22 10#11www.trulieve.com Regional Hubs: Cultivation, Processing, Retail Capacity CA SOUTHWEST 23 stores >0.4M ft² cultivation & processing AZ CO 186 Stores As of April 30, 2023 All stores owned, operated, or affiliated >4.0 M ft² Cultivation & Processing As of December 31, 2022 CT PA OH WV MD GA FL NORTHEAST 36 stores Operational Arizona California >0.5M ft² MA cultivation & processing Colorado Connecticut SOUTHEAST 127 stores >3.1M ft² cultivation & processing Florida Georgia Maryland Massachusetts Pennsylvania West Virginia Pre-Revenue Ohio 11#12www.trulieve.com Retail Footprint • . Retail Presence 186 dispensaries in nine states 33% located outside of Florida Expansion • • Driven by demand and retail metrics Add 15-20 new stores in 2023 Relocate up to six stores in 2023 New Stores Zoning, density of customers. Customer feedback, wait times Repositioning • Scale and increased traffic Improved lease options veet ALES CINTAS 12#13www.trulieve.com Cornerstone Markets: Florida, Pennsylvania, Arizona Limited license markets Leading market presence in retail Cultivation, processing and manufacturing operations Potential for expansion, optimization and brand distribution Potential future catalysts with adult use expansion in Florida and Pennsylvania Fast and favorable returns on capital investments 13#14www.trulieve.com Cornerstone Market: Florida Limited License Medical Market Trulieve operates 125 medical dispensaries Florida market has 22 vertical licenses issued and 564 approved dispensaries as of April 28, 2023 Optimizing supply chain capacity, including ramp of new 750K ft² indoor facility Increasing production of differentiated products across all segments and form factors in response to customer preferences Trulleve 14#15www.trulieve.com Cornerstone Market: Pennsylvania 000 0000 Trulieve Limited License Medical Market • 19 affiliated retail locations • • Pennsylvania market has 50 retail permits (3 locations per permit), 25 grower/processor licenses, and up to 10 research/clinical permits Ongoing optimization of indoor cultivation and processing capacity through affiliated facilities Expanding sales of internal brands including Cultivar, Modern Flower, Muse, and R.O. Trulieve Trulieve 200 Trulieve Trulieve NOTICE 15#16Cornerstone Market: Arizona Limited License Adult Use and Medical Market Trulieve operates 20 retail dispensaries Arizona market has 131 core vertical licenses, 13 rural/underserved county licenses, and 26 future social equity licenses Optimizing supply chain capacity to support additional branded product launches Opened three Trulieve branded locations in Phoenix, Sierra Vista, and Tucson in 2022 Began statewide rebranding efforts with Glendale location in November 2022 CAR ЕСТ HARVEST MARVEST HARVEST 0 HARVEST www.trulieve.com opness Cutad RECREATIONAL CUSTOMER LINE FORMS HER 16#17www.trulieve.com ES Distribution of Branded Products through Branded Retail and Wholesale Channels WWIELDWORY STOP PREMIUM Trulieve Brands Collection AVENUE™ Thank You! VALUE MID Muse A Alchemy MOMENTA Roll One ALL THE WEED YOU NEED MODERN FLOWER Loveli TM Sweet TALK colors TM 17#18www.trulieve.com Distribution of Branded Products through Branded Retail and Wholesale Channels. LOVE'S OVEN binske Partner Brands W 0 G BELLAMY SUNSHINE + CANNABIS Math CANNABIS BLUE RIVER™ Bhang Truie rn your ruPerks today. Happy y Birthday Tralove Your T: YOU! BLACK TUNA It makes you feel like dancing! CONNECTED DeJisioso Altaylulis Khalifa Kush El Blunto THE WORLD'S FINEST CANNABIS EXPERIENCE 18#19404 Trulieve WOCH THE Leadership#20www.trulieve.com Executive Leadership KIM RIVERS Founder, Chairman, Chief Executive Officer Over 15 years of experience running successful businesses from real estate to finance. Legal background in M&A and securities law. Rivers serves as second vice chair for the National Cannabis Roundtable. ALEX D'AMICO Chief Financial Officer Over 20 years of accounting and finance experience in technology, healthcare entertainment and advertising. He has held several senior finance and executive roles at Cognizant, Deloitte, Quest Diagnostics, Synvista Therapeutics and Telaria. KYLE LANDRUM Chief Production Officer Over 15 years of experience with leadership roles in cannabis and restaurant industries. Joined Trulieve in 2017, helping the company manage rapid growth while scaling operations across cultivation, manufacturing, construction, and supply chain management. STEVE WHITE President Over 10 years of cannabis experience as CEO and Co-Founder of Harvest Health & Recreation with legal background as former litigator. Pioneer in advancement of regulated cannabis industry. TIM MOREY Chief Sales Officer Over 20 years of retail leadership and operations experience with prior roles at Foot Locker, Finish Line and Gamestop. ERIC POWERS Chief Legal Officer Over 25 years of broad legal experience with a background in corporate and tax law, both in-house and private practice including senior roles at Crawford & Company. 20#21www.trulieve.com Board of Directors KIM RIVERS, Founder, Chairman, Chief Executive Officer Experienced entrepreneur with successful track record in multiple sectors including cannabis and real estate. Rivers joined Trulieve at its inception and has been the key driver for the Company's customer-centric vision, strong growth, strategic expansion, and industry-leading profitability. Prior to Trulieve, Ms. Rivers spent several years as an attorney in private practice specializing in mergers, acquisitions, and securities for multi-million-dollar corporations. GIANNELLA ALVAREZ, Director Experienced executive with focus on strategic planning, branding, innovation, consumer insights, technology, and scaling and leading multi- billion-dollar businesses. Previously CEO of Beanitos, Inc., a privately held snack food company, and Harmless Harvest, Inc., a privately held organic food and beverage company. Her experience includes senior global leadership roles at The Coca-Cola Company, The Procter and Gamble Co. and Kimberly Clark. RICHARD MAY, Director President and Co-Owner of May Nursery, Inc. with almost two decades of growing and management experience. May has served on several agricultural and civic boards including the Southern Nursery Association and the Gadsden County Chamber of Commerce. May is a founding member of Trulieve. JANE MORREAU, Director Seasoned global finance executive with a broad skillset and expertise. Experience includes supply chain management, manufacturing operations, information technology, retail operations, mergers and acquisitions and corporate strategy. Morreau formerly served as Executive Vice President and Chief Financial Officer of Brown-Forman Corporation. PETER T. HEALY, Lead Director Attorney with a focus on capital markets, M&A, and private equity transactions. Clients have included corporate issuers, Wall Street underwriters, and private equity firms. Substantial experience representing issuers and underwriters in public offerings and private placements, private equity firms and sovereign wealth funds in their investment activities, and corporate boards in governance matters and strategic transactions. THAD BESHEARS, Director Co-Owner/President of Simpson Nurseries of FL and TN where he develops and implements strategic vision while monitoring the market for opportunities for growth and expansion. Responsible for all sales operations, production, and inventory tracking. Under his guidance and oversight, the company has more than doubled annual sales. THOMAS MILLNER, Director Executive with strong combination of leadership, merchandising and multichannel experience. Served as CEO of Cabela's, a direct marketer and specialty retailer of outdoor recreation merchandise, for nearly a decade. Prior to Cabela's, Milner spent 14 years as president and CEO of North Carolina's Remington Arms Company. SUSAN THRONSON, Director Independent director with global digital, ecommerce and loyalty marketing experience. Thronson was Senior Vice President of Global Marketing for Marriott International, leading Marriott's worldwide integrated marketing strategy and execution for its 15 hotel brands. 21#22Financials#23www.trulieve.com Recent Developments • First to launch medical sales in Georgia with two new dispensaries in Macon and Marietta Opened three dispensaries in Palatka and Winter Haven, Florida and Beckley, West Virginia Launched adult-use sales in Bristol, Connecticut First U.S. cannabis company to launch advertising campaigns on Twitter Launched proprietary brands Modern Flower and Roll One in Massachusetts and West Virginia Contributed $10.5 million to the Smart and Safe Florida campaign, which aims to legalize adult use marijuana in Florida through a ballot initiative in November 2024 Currently operate 186 retail dispensaries and over 4 million square feet of cultivation and processing capacity in the United States 23#24www.trulieve.com 2023 Objectives Cash Generation and Preservation Plans: • ● • . • Shuttering of margin and cash dilutive assets Adjust production mix and capacity utilization • Optimize assortment to match customer preferences Pullback of legacy FL production sites - banked capacity Reduce inventory throughout 2023 Ramp new 750K indoor production facility Lower production costs over time Reduce wages with elimination of redundancies Investments in the Future: . Smart and Safe Florida Campaign . New market and retail development • ● Technology platforms for integrated commerce environment Consideration of strategic M&A opportunities 24#25www.trulieve.com Financial Highlights* INCOME STATEMENT HIGHLIGHTS (USD millions) Q4:22 Q3:22 Q2:22 Q1:22 Q4:21 2022 2021 Revenue 302.2 300.8 319.1 317.7 304.9 1239.8 938.0 Gross Profit 149.7 168.0 183.8 180.5 134.1 682.0 567.8 Gross Margin 49.5% 55.9% 57.6% 56.8% 44.0% 55.0% 60.5% Adjusted Gross Profit 162.1 171.9 183.7 185.3 180.6 702.9 621.4 Adjusted Gross Margin 53.6% 57.1% 57.6% 58.3% 59.2% 56.7% 66.2% SG&A 125.8 113.6 108.9 106.4 116.9 454.7 315.7 SG&A as % Revenue 41.6% 37.8% 34.1% 33.5% 38.3% 36.7% 33.7% Adjusted SG&A 94.4 92.0 91.9 95.1 96.4 373.4 274.2 Adjusted SG&A as % Revenue 31.2% 30.6% 28.8% 29.9% 31.6% 30.1% 29.2% Depreciation and Amortization 30.7 30.2 30.0 28.4 27.4 119.4 47.2 Net Income (Loss)** (77.0) (114.6) (22.5) (32.0) (71.5) (246.1) 18.0 Net Income (Loss) Continuing Operations (75.9) (77.0) (22.1) (30.1) (70.2) (205.2) 19.4 Adjusted Net Income (Loss) (34.7) 3.5 (0.6) 1.7 1.5 (30.1) 123.4 EPS** (0.41) (0.61) (0.12) (0.16) (0.49) (1.31) 0.12 EPS Continuing Operations (0.40) (0.41) (0.11) (0.16) (0.48) (1.06) 0.14 Adjusted EPS (0.18) 0.02 0.00 0.01 0.01 (0.16) 0.84 Adjusted EBITDA 84.7 98.8 111.3 105.4 100.9 400.1 384.6 Adjusted EBITDA Margin 28.0% 32.8% 34.9% 33.2% 33.1% 32.3% 41.0% *Adjusted gross profit, adjusted gross margin, adjusted net income, adjusted EPS, adjusted EBITDA and adjusted EBITDA Margin are Non-GAAP financial measures. See slides 27-29 for reconciliation to GAAP for all Non-GAAP financial measures. **Includes discontinued operations. 25#26www.trulieve.com Financial Highlights BALANCE SHEET HIGHLIGHTS (USD millions) Cash Debt SHARE COUNT ESTIMATE Q4:22 219 648 553 552 Q3:22 Q2:22 Q1:22 Q4:21 114 181 267 234 553 479 (millions as of December 31, 2022 on as if converted basis) Subordinate Voting Shares Multiple Voting Shares* Total Shares Outstanding 159.8 0.3 186.0 * converted at 100 subordinate shares per 1 multiple voting share Employee Stock Options/RSUS Equity Warrants excludes 0.867 million unexercisable options excludes 0.902 million nonvested RSUS Pro Forma Estimated Shares 5.4 0.2 191.6 26#27www.trulieve.com Reconciliation of Non-GAAP Financial Measures (Amounts expressed in millions of United States dollars) Net Income (Loss) GAAP Add (Deduct) Impact of: Interest Expense, net Provision For Income Taxes Depreciation and Amortization Depreciation in COGS EBITDA Impairment and Disposal of Long-lived Assets Results of Discontinued Operations Acquisition and Transaction Costs Integration and Transition Costs Other Non-Recurring Expenses Share-Based Compensation Legislative Campaign Contributions Inventory Step Up Fair Value Covid Related Expenses Other Expense (Income), net Fair Value of Derivative Liabilities - Warrants Non-Controlling Interest Adjusted EBITDA Non-GAAP For the Three Months Ended For the Full Year Ended December 31, 2022 December 31, 2021 September 30, December 31, 2022 December 31, 2021 2022 $ (77.0) $ (71.5) $ (114.6) $ (246.1) $ 18.0 sssst es es $ 23.0 $ 45.1 $ 30.7 $ 13.4 35.2 ՄՌ Ռ Ռ ՄՌ 14.1 41.4 27.4 9.7 21.1 es es es es $ 19.3 $ 79.8 34.8 $ 28.2 161.8 146.7 $ 30.2 119.4 47.2 $ 14.6 52.5 24.1 ՄՌ (22.3) 167.4 270.8 es es $ (0.6) 5.4 $ 5.2 1.9 es ist es es 7.5 1.5 es es es 54.6 75.5 5.4 $ 38.1 47.6 1.9 7.0 24.8 15.8 $ 4.0 22.9 $ 16.3 3.4 $ 3.6 7.0 ՄՌ ՄՌ 6.7 21.1 25.6 1.9 27.8 5.1 4.3 18.1 13.4 10.0 0.0 10.0 20.0 0.0 $ 0.0 38.0 0.0 1.0 41.2 0.0 0.2 0.2 0.8 6.2 es es es es 1.6 (0.7) (0.4) (1.4) (1.1) (0.0) (0.2) (0.4) (2.6) (0.2) $ 1.9 0.5 $ (0.9) (0.0) 0.5 $ 84.7 100.9 98.8 400.1 384.6 27#28www.trulieve.com Reconciliation of Non-GAAP Financial Measures (Amounts expressed in millions of United States dollars) Gross Profit GAAP Gross Margin % GAAP For the Three Months Ended For the Full Year Ended December 31, 2022 December 31, September 30, December 31, 2022 December 31, 2021 2021 2022 $ 149.7 $ 134.1 $ 168.0 $ 50% 44% 56% 682.0 55% $ 567.8 61% Add (Deduct) Impact of: Inventory Step Up Fair Value 0.0 38.0 0.0 1.0 41.2 Transaction, Acquisition, and Integration Costs 12.4 8.5 3.8 19.8 $ 12.4 Adjusted Gross Profit Non-GAAP 162.1 180.6 171.9 702.9 621.4 Adjusted Gross Margin % Non-GAAP 54% 59% 57% 57% 66% 28#29www.trulieve.com Reconciliation of Non-GAAP Financial Measures For the Three Months Ended For the Full Year Ended (Amounts expressed in millions of United States dollars) Net Income (Loss) GAAP December 31, December 31, September 30, December 31, 2022 December 31, 2021 2022 2021 2022 $ (77.0) $ (71.5) $ (114.6) $ (246.1) $ 18.0 Add (Deduct) Impact of: Share-Based Compensation Related Premiums 0.0 0.0 0.0 $ 0.0 4.2 Warrant Liability Adjustment (0.0) (0.2) (0.4) $ (2.6) (0.2) Inventory Step Up Fair Value 0.0 38.0 0.0 $ 1.0 41.2 Transaction, Acquisition, and Integration Costs 37.8 27.9 25.5 93.7 46.5 Covid Related Expenses 0.0 0.2 0.2 $ 0.8 6.2 Impairment and Disposal of Long-lived Assets $ (0.6) 5.4 54.6 $ 75.5 5.4 Results of Discontinued Operations $ 5.2 $ 1.9 38.1 $ 47.6 1.9 Adjusted Net Income Non-GAAP $ (34.7) 1.5 3.5 $ (30.1) 123.2 For the Three Months Ended For the Full Year Ended (Amounts expressed in millions of United States December 31, December 31, September 30, December 31, 2022 December 31, 2021 dollars) 2022 2021 2022 Earnings (Loss) Per Share GAAP $ (0.41) $ (0.49) $ (0.61) $ (1.31) $ 0.12 Add (Deduct) Impact of: Share-Based Compensation Related Premiums $ 0.00 0.00 0.00 $ Warrant Liability Adjustment $ (0.00) (0.00) (0.00) et st 0.00 0.03 $ (0.01) (0.00) Inventory Step Up Fair Value 0.00 0.26 0.00 0.01 0.28 Transaction, Acquisition, and Integration Costs 0.20 0.19 0.14 0.50 0.32 Covid Related Expenses 0.00 0.00 0.00 0.00 0.04 Impairment and Disposal of Long-lived Assets (0.00) 0.04 0.29 es 0.40 0.04 Results of Discontinued Operations $ 0.03 0.01 0.20 $ 0.25 0.01 Adjusted Earnings Per Share Non-GAAP $ (0.18) $ 0.01 ՄՌ $ 0.02 $ (0.16) Ռ 0.84 29#30Thank You CSE: TRUL OTCQX: TCNNF [f] @Trulieve/@Trulieve_IR [email protected]